Toxic Epidermal Necrolysis clinical trials at UC Davis
1 research study open to eligible people
“Treatment of toxic epidermal necrolysis/Stevens-Johnson’s Syndrome with topical steroid to characterize the genetic makeup of the disease.”
open to eligible people ages 7-85
The primary objectives of this study are to investigate the efficacy and safety of topical steroid ointment (clobetasol 0.05%) for the treatment of the cutaneous manifestations of toxic epidermal necrolysis (TEN).